Related references
Note: Only part of the references are listed.A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17+ cell frequency
Simone Punt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
Alexander W. Eckert et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
Steven B. Chinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression
Nathalie Bonnefoy et al.
ONCOIMMUNOLOGY (2015)
Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulators
Stephen M. Hatfield et al.
ONCOIMMUNOLOGY (2015)
Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma
Simona Partlova et al.
ONCOIMMUNOLOGY (2015)
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
Deepak Mittal et al.
CANCER RESEARCH (2014)
Molecular mechanisms of ATP secretion during immunogenic cell death
I. Martins et al.
CELL DEATH AND DIFFERENTIATION (2014)
Targeting Cancer-Derived Adenosine: New Therapeutic Approaches
Arabella Young et al.
CANCER DISCOVERY (2014)
Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
Michail V. Sitkovsky et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Bertrand Allard et al.
CLINICAL CANCER RESEARCH (2013)
The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities
Monika E. Freiser et al.
IMMUNOLOGIC RESEARCH (2013)
Randomized Phase III Trial of Induction Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil Followed by Surgery Versus Up-Front Surgery in Locally Advanced Resectable Oral Squamous Cell Carcinoma
Lai-ping Zhong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
Christel Devaud et al.
ONCOIMMUNOLOGY (2013)
The adenosinergic system in cancer Key therapeutic target
Rosalinda Sorrentino et al.
ONCOIMMUNOLOGY (2013)
Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms
Jingjing Quan et al.
CANCER AND METASTASIS REVIEWS (2012)
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
Adam T. Waickman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Chemopreventive and Chemotherapeutic Actions of mTOR Inhibitor in Genetically Defined Head and Neck Squamous Cell Carcinoma Mouse Model
Zhi-Jun Sun et al.
CLINICAL CANCER RESEARCH (2012)
Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation
Y. Bian et al.
ONCOGENE (2012)
The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
Akio Ohta et al.
FRONTIERS IN IMMUNOLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Beat M. Kuenzli et al.
PURINERGIC SIGNALLING (2011)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
John Stagg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
Cherry L. Estilo et al.
BMC CANCER (2009)
Progressive Tumor Formation in Mice with Conditional Deletion of TGF-β Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway
Yansong Bian et al.
CANCER RESEARCH (2009)
Regulatory T cells: how do they suppress immune responses?
Shimon Sakaguchi et al.
INTERNATIONAL IMMUNOLOGY (2009)
Dysregulated molecular networks in head and neck carcinogenesis
Alfredo A. Molinolo et al.
ORAL ONCOLOGY (2009)
T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
Michail V. Sitkovsky
TRENDS IN IMMUNOLOGY (2009)
HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak
Julio C. Morote-Garcia et al.
BLOOD (2008)
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: Mechanisms of suppression and expansion in advanced disease
Christoph Bergmann et al.
CLINICAL CANCER RESEARCH (2008)
Head and neck cancer: Changing epidemiology, diagnosis, and treatment
Shanthi Marur et al.
MAYO CLINIC PROCEEDINGS (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma
Shyun-Yeu Liu et al.
ORAL ONCOLOGY (2008)
A(2A) receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Paul E. Zarek et al.
BLOOD (2008)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine
James J. Kobie et al.
JOURNAL OF IMMUNOLOGY (2006)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Development and function of naturally occurring CD4(+)CD25(+) regulatory T cells
Akiko Toda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
GS protein-coupled adenosine receptor signaling and lytic function of activated NK cells
T Raskovalova et al.
JOURNAL OF IMMUNOLOGY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck
I Kuss et al.
CLINICAL CANCER RESEARCH (2004)
Role of tissue stroma in cancer cell invasion
O De Wever et al.
JOURNAL OF PATHOLOGY (2003)
Share Paper
